chr19-16479172-C-G
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_145046.5(CALR3):āc.1114G>Cā(p.Glu372Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00012 in 1,614,100 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E372K) has been classified as Uncertain significance.
Frequency
Consequence
NM_145046.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CALR3 | NM_145046.5 | c.1114G>C | p.Glu372Gln | missense_variant | 9/9 | ENST00000269881.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CALR3 | ENST00000269881.8 | c.1114G>C | p.Glu372Gln | missense_variant | 9/9 | 1 | NM_145046.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152102Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000274 AC: 69AN: 251488Hom.: 0 AF XY: 0.000309 AC XY: 42AN XY: 135920
GnomAD4 exome AF: 0.000120 AC: 175AN: 1461880Hom.: 0 Cov.: 31 AF XY: 0.000140 AC XY: 102AN XY: 727240
GnomAD4 genome AF: 0.000125 AC: 19AN: 152220Hom.: 0 Cov.: 31 AF XY: 0.0000940 AC XY: 7AN XY: 74432
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 22, 2023 | The c.1114G>C (p.E372Q) alteration is located in exon 9 (coding exon 9) of the CALR3 gene. This alteration results from a G to C substitution at nucleotide position 1114, causing the glutamic acid (E) at amino acid position 372 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Hypertrophic cardiomyopathy 19 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Dec 21, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at